(Q36193701)

12 August 2017

1 reference

title

Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literature (English)

1 reference

12 August 2017

main subject

aggressive fibromatosis

1 reference

Marry M van den Heuvel-Eibrink

inferred from title

author

8

object named as

Marry M van den Heuvel-Eibrink

1 reference

12 August 2017

7

Rob Pieters

1 reference

12 August 2017

Saskia Buitendijk

1

1 reference

12 August 2017

Cees P van de Ven

2

1 reference

12 August 2017

Ton G Dumans

3

1 reference

12 August 2017

Jan C den Hollander

4

1 reference

12 August 2017

Peter J Nowak

5

1 reference

12 August 2017

Wim J Tissing

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

104

1 reference

12 August 2017

issue

5

1 reference

12 August 2017

page(s)

1090-1099

1 reference

Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Radiotherapy in the management of aggressive fibromatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Pediatric desmoid tumor: retrospective analysis of 63 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Challenges in the treatment of childhood fibromatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. CHromosomes And Morphology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Noncytotoxic drug therapy in children with unresectable desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

The pharmacological treatment of aggressive fibromatosis: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

[Extra-abdominal fibromatosis--extra-abdominal desmoid. Review and personal experiences]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Individualizing management of aggressive fibromatoses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Long-term results with radiation therapy for pediatric desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Desmoid fibromatosis is a clonal process

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Identification of IGFBP-6 as a significantly downregulated gene by beta-catenin in desmoid tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Radiation treatment for aggressive fibromatosis: findings from observed patterns of local failure.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21275

7 January 2021

Identifiers

DOI

10.1002/CNCR.21275

1 reference

12 August 2017

1 reference